Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Karmaker, Swastika
Kolejni autorzy:	Yasmin, Hasina
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Alzheimer’s disease Rhabdomyolysis Galantamine Dementia Alzheimer's disease Neuropharmacology
Dostęp online:	http://hdl.handle.net/10361/23271

Podobne zapisy

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Wydane: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Wydane: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Wydane: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Wydane: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Wydane: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Wydane: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Wydane: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Wydane: (2022)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Wydane: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Wydane: (2021)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Wydane: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Wydane: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Wydane: (2022)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Wydane: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Wydane: (2020)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Wydane: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Wydane: (2019)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Wydane: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Wydane: (2022)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Wydane: (1993)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Wydane: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Wydane: (2024)

Mini-mental state examination in non-hospitalized post covid patients to identify cognitive decline
od: Tanjum, Silvia
Wydane: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Wydane: (2022)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, i wsp.
Wydane: (2022)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Wydane: (2024)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Wydane: (2022)

Skeleton /
od: Parkin, Peter

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Wydane: (2019)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
od: Sani, Mehedi Hasan, i wsp.
Wydane: (2022)

Status of cognitive decline in post covid-19 Bangladeshi patients
od: Bapan, Pranta Saha
Wydane: (2024)

A review on adult neurogenesis in Alzheimer’s disease
od: Akter, Moriam
Wydane: (2022)

An ambient assisted living system for Alzheimer’s patients
od: Abedin, Minhajul, i wsp.
Wydane: (2023)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
od: Mahbub, Riasat, i wsp.
Wydane: (2022)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
od: Roy, Aditya, i wsp.
Wydane: (2023)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
od: Alam, Badrul, i wsp.
Wydane: (2016)

Detection of alzheimer's disease using deep learning
od: Hasan, Mahmudul, i wsp.
Wydane: (2021)

Multi-classification based Alzheimer's disease detection with comparative analysis from brain MRI scans using deep learning
od: Kabir, Azmain, i wsp.
Wydane: (2022)

Detecting different stages of Alzheimer’s disease from MRI images using deep learning and computer vision techniques
od: Rahman, Fardin, i wsp.
Wydane: (2024)

A review on optogenetics and its potential in neurological disorder management
od: Armin, Fariza
Wydane: (2024)